What question did this study set out to answer?

To review clinical evidence, regulatory milestones, emerging technologies, and implementation challenges associated with prescription digital therapeutics across various clinical conditions.

August 16, 2026Open Access

Digital Therapeutics: Bridging the Gap Between Evidence-Based Software Interventions and Clinical Practice—current Applications, Regulatory Landscape and Emerging Technologies

View Full Paper

Ask AI

Bookmark

Authors

RKRuba Sree N.1 Varshini K.1*

Discussion

Member takes

Implication

Systematic review demonstrates strong clinical efficacy and safety of prescription digital therapeutics across diverse disorders, indicating their growing role in scalable personalized healthcare.

Key Points

To review clinical evidence, regulatory milestones, emerging technologies, and implementation challenges associated with prescription digital therapeutics across various clinical conditions.
Systematically reviewed randomized controlled trials and clinical evidence on prescription digital therapeutics in pediatric and adult populations.
Assessed therapeutic interventions across neurodevelopmental conditions, psychiatric disorders, and chronic disease management.
Prescription digital therapeutics showed strong safety profiles and therapeutic effect sizes on par with conventional clinical interventions.
FDA-cleared digital therapeutics for attention-deficit/hyperactivity disorder and amblyopia demonstrated response rates exceeding 60% in pediatric cohorts.
Major implementation hurdles identified include complex reimbursement pathways, provider adoption barriers, and socioeconomic health equity gaps.

Cite This Study

Ruba Sree N.1 Varshini K.1* (2026) studied this question.

synapsesocial.com/papers/6a817980f2fb91fc834aca27 https://doi.org/10.5281/zenodo.21914298

View Full Paper

Ask AI

Bookmark

Implication

Systematic review demonstrates strong clinical efficacy and safety of prescription digital therapeutics across diverse disorders, indicating their growing role in scalable personalized healthcare.

Digital Therapeutics: Bridging the Gap Between Evidence-Based Software Interventions and Clinical Practice—current Applications, Regulatory Landscape and Emerging Technologies

Discussion

Member takes

Implication

Key Points

Cite This Study

Digital Therapeutics: Bridging the Gap Between Evidence-Based Software Interventions and Clinical Practice—current Applications, Regulatory Landscape and Emerging Technologies

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider